Fondazione IRCCS Policlinico San Matteo — Pavia, Pavia

Public research footprint of Fondazione IRCCS Policlinico San Matteo, compiled from the ClinicalTrials.gov public registry.

572

Registered studies

280

Active

180

Recruiting now

193

Completed

Stopped or withdrawn

Most-studied conditions

Diffuse Large B-cell Lymphoma (DLBCL) · Accelerated Phase Chronic Myeloid Leukemia · Transthyretin Amyloid Cardiomyopathy (ATTR CM) · Leukemia, Myeloid, Acute

Recently updated registry entries

NCT05878769 — A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic… (Recruiting)
NCT07210723 — A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic… (Recruiting)
NCT06563895 — Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Fondazione IRCCS Policlinico San Matteo?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.